Findings hold promise for developing regenerative therapies for spinal cord injuries and diseases such as multiple sclerosis
Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of UC Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin — a fatty, insulating sheath essential to normal neural conduction.
“Our findings represent an important conceptual advance in stem cell research,” said Wenbin Deng, principal investigator of the study and associate professor at the UC Davis Department of Biochemistry and Molecular Medicine. “We have bioengineered the first generation of myelin-producing cells with superior regenerative capacity.”
The brain is made up predominantly of two cell types: neurons and glial cells. Neurons are regarded as responsible for thought and sensation. Glial cells surround, support and communicate with neurons, helping neurons process and transmit information using electrical and chemical signals. One type of glial cell — the oligodendrocyte — produces a sheath called myelin that provides support and insulation to neurons. Myelin, which has been compared to insulation around electrical wires that helps to prevent short circuits, is essential for normal neural conduction and brain function; well-recognized conditions involving defective myelin development or myelin loss include multiple sclerosis and leukodystrophies.
In this study, the UC Davis team first developed a novel protocol to efficiently induce embryonic stem cells (ESCs) to differentiate into oligodendroglial progenitor cells (OPCs), early cells that normally develop into oligodendrocytes. Although this has been successfully done by other researchers, the UC Davis method results in a purer population of OPCs, according to Deng, with fewer other cell types arising from their technique.
They next compared electrophysiological properties of the derived OPCs to naturally occurring OPCs. They found that unlike natural OPCs, the ESC-derived OPCs lacked sodium ion channels in their cell membranes, making them unable to generate spikes when electrically stimulated. Using a technique called viral transduction, they then introduced DNA that codes for sodium channels into the ESC-derived OPCs. These OPCs then expressed ion channels in their cells and developed the ability to generate spikes.
According to Deng, this is the first time that scientists have successfully generated OPCs with so-called spiking properties. This achievement allowed them to compare the capabilities of spiking cells to non-spiking cells.
In cell culture, they found that only spiking OPCs received electrical input from neurons, and they showed superior capability to mature into oligodendrocytes.
They also transplanted spiking and non-spiking OPCs into the spinal cord and brains of mice that are genetically unable to produce myelin. Both types of OPCs had the capability to mature into oligo-dendrocytes and produce myelin, but those from spiking OPCs produced longer and thicker myelin sheaths around axons.
“We actually developed ‘super cells’ with an even greater capacity to spike than natural cells,” Deng said. “This appears to give them an edge for maturing into oligodendrocytes and producing better myelin.”
It is well known that adult human neural tissue has a poor capacity to regenerate naturally. Although early cells such as OPCs are present, they do not regenerate tissue very effectively when disease or injury strikes.
Deng believes that replacing glial cells with the enhanced spiking OPCs to treat neural injuries and diseases has the potential to be a better strategy than replacing neurons, which tend to be more problematic to work with. Providing the proper structure and environment for neurons to live may be the best approach to regenerate healthy neural tissue. He also notes that many diverse conditions that have not traditionally been considered to be myelin-related diseases – including schizophrenia, epilepsy and amyotrophic lateral sclerosis (ALS) – actually are now recognized to involve defective myelin.
The Latest Bing News on:
Stem cell technology
- Locusts can differentiate between cancer cells and healthy cells, research showson August 5, 2022 at 5:30 pm
Researchers at Michigan State University have shown that locusts can not only "smell" the difference between cancer cells and healthy cells, but they can also distinguish between different cancer cell ...
- The Download: repairing pig cells and Pelosi’s trip fallouton August 5, 2022 at 5:00 am
A new system called OrganEx stopped the deterioration of cells in pig organs one hour after the animal’s death, a finding that suggests cells don’t die as quickly as previously understood. The ...
- Improving gettering tech for TOPCon solar cellson August 5, 2022 at 12:57 am
Scientists in Australia have looked at how gettering technologies could improve passivating contacts based on polysilicon and silicon monoxide (SiOx) for tunnel oxide passivated contact (TOPCon) solar ...
- Yale researchers use new technology to restore dead pig cellson August 4, 2022 at 6:55 pm
Researchers at Yale used new technology to reanimate dead pig cells leading to a potential breakthrough for organ transplants. NBC News’ Joshua Johnson is joined by the director of transplant ethics ...
- Making better, ready-made CAR T cells for cancer immunotherapyon August 4, 2022 at 8:00 am
it seems that iPS cells are finally yielding new therapeutic approaches to the treatment of diseases like cancer," says Daley. Boston Children's and ElevateBio, a technology-driven company focused ...
- Pig Cells Restored through Death-Defying OrganEx Technologyon August 4, 2022 at 5:00 am
A new technology that delivers a cell-protective fluid to organs and tissues restored cellular functions in pigs a full hour after their deaths.
- Researchers repaired cells in damaged pig organs an hour after the animal’s deathon August 4, 2022 at 1:43 am
The system, previously used to return circulation to severed pigs’ brains, can now restore some functions of cells in other vital organs ...
- Yale-developed technology restores cell, organ function in pigs after deathon August 3, 2022 at 1:39 pm
The revolutionary technology could help extend the health of human organs during surgery and expand availability of donor organs for transplant.
- Scientists reanimate dead cells in pigs, a potential breakthrough for organ transplantson August 3, 2022 at 8:04 am
Researchers at Yale University used a new technology to restore cells in some organs of pigs that had just died, bringing the animals’ cells back to function. The findings, which were published ...
- Global Stem Cells Group Expands Its Stem Cell Therapy and Regenerative Medicine Centers to Indonesiaon August 1, 2022 at 4:00 am
LAS VEGAS, NV, Aug. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Meso Numismatics, Inc. ("Meso Numismatics" or the "Company") (MSSV), a technology company specializing in Biotech and Numismatics, i ...
The Latest Google Headlines on:
Stem cell technology
The Latest Bing News on:
Regenerative therapies for spinal cord injuries and diseases
- Methylprednisolone and Other Confounders to Spinal Cord Injury Clinical Trialson August 5, 2022 at 5:00 pm
A number of diverse neuroprotective regimens are in, or progressing towards, clinical trials for spinal cord ... 72 h post injury, which is outside the window for use of many therapies.
- Mesenchymal Stem Cells Market By Industry Size, Share, Revenue, Regions, And Forecast To 2031on August 4, 2022 at 1:06 am
The global mesenchymal stem cells market is estimated to grow on the back of increasing demand for regenerative ... and rare diseases, including osteoporosis, cancer, spinal cord injuries, type ...
- Pain volume control: a link between chronic pain and opioid abuse in the brain - OSU, UM research suggestson August 3, 2022 at 11:45 am
Patients with fibromyalgia and those prone to opioid addiction may have something in common, researchers say: the part of the brain that controls the body’s perception of pain has the volume cranked ...
- Children and teens getting spinal surgery don't need so many opioids, study suggestson August 3, 2022 at 7:24 am
A Michigan Medicine study finds that children and teens with scoliosis undergoing spinal fusion can be prescribed fewer opioids while still receiving adequate pain control after surgery.
- NervGen Pharma delivers “gold standard” in clinical trial, says iA Capitalon July 29, 2022 at 5:35 pm
In a new report on Friday, Stellick reiterated her “Speculative Buy” rating on NervGen Pharma, saying the company could have over a $10 billion annual market ahead of it for its lead drug candidate.
- Peptide Promotes Nervous System Repair in Stroke Animal Modelson July 29, 2022 at 5:00 am
NVG-291-R shows significant behavioral recovery accompanied by neuroprotection, axonal sprouting, and neuroblast migration in stoke lesions.
- Cell Therapy Market To Generate $35.95 Billion, Regenerative Therapy And 3D Printing To Remain In Limelighton July 26, 2022 at 7:42 am
Parkinson's disease and spinal cord injury. As per latest study by SkyQuest, most of the companies offering regenerative cell therapy are located in North America. To be precise, North America is ...
- Cell Therapy Market to Generate $35.95 billion, Regenerative Therapy and 3D Printing to Remain in Limelighton July 26, 2022 at 6:59 am
cell therapy market has gained immense popularity and emerged as a leading approach in regenerative medicine for treating a wide range of diseases and injuries, including heart disease, stroke, ...